Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
T cell receptor alpha constant | 0.691 | 0.615 |
|
disease | 0.300 | strong | 1.000 | 1 | 0 | 1986 | 1986 | |||||||||
|
RecQ like helicase 4 | 0.496 | 0.808 | 3.3E-35 |
|
disease | 0.300 | limited | 1.000 | 1 | 0 | 2006 | 2006 | ||||||||
|
tetratricopeptide repeat domain 7A | 0.641 | 0.577 | 1.5E-31 |
|
disease | 0.330 | strong | 1.000 | 1 | 0 | 2013 | 2014 | ||||||||
|
dedicator of cytokinesis 8 | 0.578 | 0.731 | 1.5E-11 |
|
disease | 0.400 | strong | 1.000 | 1 | 0 | 2009 | 2019 | ||||||||
|
regulatory factor X5 | 0.650 | 0.577 | 2.0E-11 |
|
disease | 0.300 | strong | 1.000 | 1 | 0 | 1997 | 1997 | ||||||||
|
capping protein regulator and myosin 1 linker 2 | 0.695 | 0.462 | 2.9E-11 |
|
disease | 0.410 | strong | 1.000 | 1 | 0 | 2017 | 2018 | ||||||||
|
IL2 inducible T cell kinase | 0.555 | 0.769 | 3.1E-08 |
|
disease | 0.300 | strong | 1.000 | 1 | 0 | 2011 | 2011 | ||||||||
|
adenosine deaminase 2 | 0.545 | 0.846 | 8.1E-08 |
|
disease | 0.300 | strong | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
DNA cross-link repair 1C | 0.544 | 0.808 | 2.5E-07 |
|
disease | 0.320 | strong | 1.000 | 0 | 0 | 2013 | 2018 | ||||||||
|
DNA ligase 4 | 0.478 | 0.846 | 4.2E-06 |
|
disease | 0.320 | strong | 1.000 | 0 | 0 | 2006 | 2016 | ||||||||
|
purine nucleoside phosphorylase | 0.527 | 0.885 | 7.0E-06 |
|
disease | 0.320 | strong | 1.000 | 0 | 0 | 2014 | 2020 | ||||||||
|
phosphoglucomutase 3 | 0.610 | 0.769 | 1.5E-05 |
|
disease | 0.300 | strong | 1.000 | 1 | 0 | 2014 | 2014 | ||||||||
|
CD3g molecule | 0.695 | 0.346 | 1.7E-05 |
|
disease | 0.300 | strong | 1.000 | 1 | 0 | 2007 | 2007 | ||||||||
|
ORAI calcium release-activated calcium modulator 1 | 0.520 | 0.808 | 1.9E-05 |
|
disease | 0.320 | strong | 1.000 | 1 | 0 | 2009 | 2018 | ||||||||
|
transferrin receptor | 0.437 | 0.885 | 7.0E-05 |
|
disease | 0.400 | limited | 1.000 | 1 | 0 | 2016 | 2016 | ||||||||
|
unc-119 lipid binding chaperone | 0.691 | 0.462 | 1.5E-04 |
|
disease | 0.300 | limited | 1.000 | 1 | 0 | 2012 | 2012 | ||||||||
|
TNF receptor superfamily member 4 | 0.547 | 0.692 | 1.5E-04 |
|
disease | 0.300 | limited | 0 | 0 | |||||||||||
|
non-homologous end joining factor 1 | 0.705 | 0.385 | 4.2E-03 |
|
disease | 0.310 | strong | 1.000 | 0 | 0 | 2017 | 2017 | ||||||||
|
CD27 molecule | 0.517 | 0.692 | 1.0E-02 |
|
disease | 0.310 | strong | 1.000 | 1 | 0 | 2013 | 2015 | ||||||||
|
CD70 molecule | 0.542 | 0.692 | 1.0E-02 |
|
disease | 0.300 | strong | 1.000 | 1 | 0 | 2017 | 2017 | ||||||||
|
serine/threonine kinase 4 | 0.638 | 0.462 | 1.5E-02 |
|
disease | 0.310 | strong | 1.000 | 1 | 0 | 2014 | 2015 | ||||||||
|
inducible T cell costimulator | 0.502 | 0.731 | 3.1E-02 |
|
disease | 0.300 | strong | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
interleukin 2 receptor subunit alpha | 0.389 | 0.885 | 5.5E-02 |
|
disease | 0.300 | strong | 1.000 | 1 | 0 | 2014 | 2014 | ||||||||
|
ras homolog family member H | 0.666 | 0.462 | 0.15 |
|
disease | 0.300 | moderate | 1.000 | 1 | 0 | 2013 | 2013 | ||||||||
|
stromal interaction molecule 1 | 0.501 | 0.808 | 0.78 |
|
disease | 0.330 | strong | 1.000 | 1 | 0 | 2016 | 2019 |